Cryoport, Inc.

CYRX - Financial Snapshot

Industrials sector | Integrated Freight & Logistics industry

View on:
Ranks:

Metrics for CYRX

Price $8.04
Shares Outstanding 49.86M
All-Time Low $1.03
52-Week Low $4.58

Balance Statement Metrics

Net Cash / Share $3.21
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((421,314,000 - 261,057,000) / 49,856,135) = 3.2144
Net Current Assets / Share $4.49
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((484,843,000 - 261,057,000) / 49,856,135) = 4.4886
Net Tangible Assets / Share $7.01
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((774,328,000 - 163,663,000 - 261,057,000) / 49,856,135) = 7.01
Shares Outstanding Ave Change (Annual) 0.2%
Shares Δ YoY 1.91%
Avg CA Burn (Annual %) -20.16% (as of 2-20-2026)
Avg CA Burn (Quarterly %) 8.99% (as of 2-20-2026)

Earning Metrics

Max Earning Power / Share $0.08
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((410,000 / 0.105) / 49,856,135) = 0.0783
Adjusted Earning Power $-1.33
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-6,943,000 / 0.105) / 49,856,135) = -1.3263
Non-Cash Charges to Market Cap 1.59%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y) 0 (as of 2-20-2026)
Avg EBITDA (5Q) 2.7M (as of 2-20-2026)
Avg Net Income (5Y) -131.8M (as of 2-20-2026)
Avg Net Income (5Q) 13.7M (as of 2-20-2026)
Data as of: Price 03-20-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Current Dividend Streak No 2-20-2026
Consecutive Years Paid No 2-20-2026
Pays Dividend No 2-20-2026
Income indicators Value Date
EBITDA Positive Yes 2-20-2026
Net Income Positive No 2-20-2026
Current Dividend Streak No 2-20-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2025-09-30 Quarterly $6.18 309.3M ($309,333,000) 50.1M (50,068,904)
2025-06-30 Quarterly $6.26 314.8M ($314,813,000) 50.3M (50,278,559)
2025-03-31 Quarterly $3.91 196.2M ($196,162,000) 50.1M (50,137,218)
2024-12-31 Quarterly $2.92 145.5M ($145,499,000) 49.9M (49,908,254)
2024-12-31 Annual $2.92 145.5M ($145,499,000) 49.9M (49,908,254)
2024-09-30 Quarterly $3.16 156.4M ($156,425,000) 49.4M (49,430,583)
2023-12-31 Annual $3.27 160M ($159,963,000) 49M (48,971,026)
2022-12-31 Annual $4.04 195.4M ($195,437,000) 48.3M (48,334,280)
2021-12-31 Annual $5.71 283.2M ($283,172,000) 49.6M (49,616,154)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-03-17 49,856,135 -212,769
2025-11-10 50,068,904 +1,936
2025-09-22 50,066,968 -32

Short Interest Changes

Latest short-interest change: 2,368,648 shares (5.64% of float) | Days to cover: 7.25

Date Short Interest Delta Δ %
2026-03-12 2,368,648 shares -208,078 -8.08%
2026-02-27 2,576,726 shares -221,951 -7.93%
2026-02-11 2,798,677 shares -164,337 -5.55%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.